nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—CYP11B2—Hydrocortisone—rheumatoid arthritis	0.404	0.481	CbGbCtD
Etomidate—CYP11B1—Hydrocortisone—rheumatoid arthritis	0.263	0.313	CbGbCtD
Etomidate—CYP19A1—Betamethasone—rheumatoid arthritis	0.109	0.13	CbGbCtD
Etomidate—CYP19A1—Dexamethasone—rheumatoid arthritis	0.0636	0.0757	CbGbCtD
Etomidate—SLC2A1—skeletal joint—rheumatoid arthritis	0.0259	0.468	CbGeAlD
Etomidate—SLC2A1—cartilage tissue—rheumatoid arthritis	0.0174	0.315	CbGeAlD
Etomidate—Pseudoephedrine—NFATC1—rheumatoid arthritis	0.00498	0.602	CrCbGaD
Etomidate—SLC2A1—connective tissue—rheumatoid arthritis	0.00433	0.0783	CbGeAlD
Etomidate—SLC2A1—lymphoid tissue—rheumatoid arthritis	0.00317	0.0573	CbGeAlD
Etomidate—SLC2A1—digestive system—rheumatoid arthritis	0.00313	0.0566	CbGeAlD
Etomidate—Pseudoephedrine—IL2—rheumatoid arthritis	0.00173	0.209	CrCbGaD
Etomidate—CYP19A1—connective tissue—rheumatoid arthritis	0.00137	0.0248	CbGeAlD
Etomidate—Pseudoephedrine—TNF—rheumatoid arthritis	0.000584	0.0707	CrCbGaD
Etomidate—Fenoprofen—PTGS2—rheumatoid arthritis	0.000381	0.0461	CrCbGaD
Etomidate—Fenoprofen—ALB—rheumatoid arthritis	0.00034	0.0411	CrCbGaD
Etomidate—Pethidine—ALB—rheumatoid arthritis	0.000256	0.031	CrCbGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PTK2—rheumatoid arthritis	8.97e-05	0.00094	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL12—rheumatoid arthritis	8.75e-05	0.000917	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—BDKRB2—rheumatoid arthritis	8.75e-05	0.000917	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—CSF2—rheumatoid arthritis	8.66e-05	0.000908	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CCR5—rheumatoid arthritis	8.58e-05	0.000898	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCR6—rheumatoid arthritis	8.57e-05	0.000898	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IL2RB—rheumatoid arthritis	8.44e-05	0.000884	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CAT—rheumatoid arthritis	8.41e-05	0.000881	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MED1—rheumatoid arthritis	8.38e-05	0.000878	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—POMC—rheumatoid arthritis	8.38e-05	0.000878	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MTHFR—rheumatoid arthritis	8.38e-05	0.000878	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	8.37e-05	0.000877	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CCL5—rheumatoid arthritis	8.37e-05	0.000877	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HLA-A—rheumatoid arthritis	8.36e-05	0.000875	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL6R—rheumatoid arthritis	8.35e-05	0.000875	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	8.22e-05	0.000861	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SELE—rheumatoid arthritis	8.15e-05	0.000854	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—BGN—rheumatoid arthritis	8.14e-05	0.000853	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PDE2A—rheumatoid arthritis	7.99e-05	0.000837	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL2—rheumatoid arthritis	7.84e-05	0.000821	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCL3—rheumatoid arthritis	7.84e-05	0.000821	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IL2RA—rheumatoid arthritis	7.81e-05	0.000818	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ACP5—rheumatoid arthritis	7.8e-05	0.000817	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—B3GNT2—rheumatoid arthritis	7.8e-05	0.000817	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—rheumatoid arthritis	7.73e-05	0.00081	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—SAA1—rheumatoid arthritis	7.67e-05	0.000803	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ITGAM—rheumatoid arthritis	7.66e-05	0.000803	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CCR5—rheumatoid arthritis	7.54e-05	0.00079	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ALOX5—rheumatoid arthritis	7.5e-05	0.000785	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—C3—rheumatoid arthritis	7.37e-05	0.000772	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IL6ST—rheumatoid arthritis	7.33e-05	0.000768	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	7.32e-05	0.000767	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NOS2—rheumatoid arthritis	7.27e-05	0.000762	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SH2B3—rheumatoid arthritis	7.26e-05	0.000761	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PDE2A—rheumatoid arthritis	7.26e-05	0.00076	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CD80—rheumatoid arthritis	7.05e-05	0.000739	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—MTHFR—rheumatoid arthritis	7.02e-05	0.000735	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—BGN—rheumatoid arthritis	7.02e-05	0.000735	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—CCR5—rheumatoid arthritis	7e-05	0.000733	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—FN1—rheumatoid arthritis	6.8e-05	0.000712	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL12—rheumatoid arthritis	6.66e-05	0.000698	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—BDKRB2—rheumatoid arthritis	6.66e-05	0.000698	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL5—rheumatoid arthritis	6.66e-05	0.000697	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CXCL8—rheumatoid arthritis	6.62e-05	0.000694	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PLD4—rheumatoid arthritis	6.6e-05	0.000691	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	6.59e-05	0.00069	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IL6R—rheumatoid arthritis	6.54e-05	0.000685	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—GATA3—rheumatoid arthritis	6.52e-05	0.000683	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ALOX5—rheumatoid arthritis	6.46e-05	0.000677	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—rheumatoid arthritis	6.44e-05	0.000675	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ACAN—rheumatoid arthritis	6.37e-05	0.000668	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL1B—rheumatoid arthritis	6.35e-05	0.000665	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL13—rheumatoid arthritis	6.22e-05	0.000651	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TIMP1—rheumatoid arthritis	6.18e-05	0.000647	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ENO1—rheumatoid arthritis	6.11e-05	0.00064	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	6.01e-05	0.00063	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR5—rheumatoid arthritis	6e-05	0.000628	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC25A12—rheumatoid arthritis	5.99e-05	0.000628	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TYK2—rheumatoid arthritis	5.95e-05	0.000624	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—NFKB1—rheumatoid arthritis	5.93e-05	0.000621	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—POMC—rheumatoid arthritis	5.9e-05	0.000618	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL10—rheumatoid arthritis	5.89e-05	0.000617	CbGpPWpGaD
Etomidate—Hypertension—Ergocalciferol—rheumatoid arthritis	5.86e-05	0.039	CcSEcCtD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	5.86e-05	0.000614	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—rheumatoid arthritis	5.85e-05	0.000612	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NOS3—rheumatoid arthritis	5.85e-05	0.000612	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GC—rheumatoid arthritis	5.83e-05	0.000611	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGES—rheumatoid arthritis	5.83e-05	0.000611	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	5.68e-05	0.000595	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL6—rheumatoid arthritis	5.66e-05	0.000593	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—ALB—rheumatoid arthritis	5.65e-05	0.000591	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL13—rheumatoid arthritis	5.65e-05	0.000591	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—POMC—rheumatoid arthritis	5.61e-05	0.000588	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—RASGRP1—rheumatoid arthritis	5.56e-05	0.000582	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SYK—rheumatoid arthritis	5.54e-05	0.00058	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PRKCQ—rheumatoid arthritis	5.44e-05	0.00057	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PLB1—rheumatoid arthritis	5.42e-05	0.000568	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SYVN1—rheumatoid arthritis	5.4e-05	0.000565	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL21—rheumatoid arthritis	5.4e-05	0.000565	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CD4—rheumatoid arthritis	5.39e-05	0.000564	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—VEGFA—rheumatoid arthritis	5.38e-05	0.000563	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTGS2—rheumatoid arthritis	5.35e-05	0.00056	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL2RB—rheumatoid arthritis	5.33e-05	0.000559	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ENO1—rheumatoid arthritis	5.27e-05	0.000552	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	5.26e-05	0.000551	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	5.18e-05	0.000543	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TAGAP—rheumatoid arthritis	5.18e-05	0.000542	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—C5—rheumatoid arthritis	5.15e-05	0.00054	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ALB—rheumatoid arthritis	5.12e-05	0.000536	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCL5—rheumatoid arthritis	5.07e-05	0.000531	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CX3CR1—rheumatoid arthritis	5.03e-05	0.000527	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NOS3—rheumatoid arthritis	4.9e-05	0.000513	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL2RB—rheumatoid arthritis	4.84e-05	0.000507	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCR6—rheumatoid arthritis	4.84e-05	0.000507	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MED1—rheumatoid arthritis	4.75e-05	0.000498	CbGpPWpGaD
Etomidate—Pain—Ergocalciferol—rheumatoid arthritis	4.74e-05	0.0315	CcSEcCtD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	4.69e-05	0.000491	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—C5—rheumatoid arthritis	4.68e-05	0.00049	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PTK2—rheumatoid arthritis	4.62e-05	0.000484	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—rheumatoid arthritis	4.61e-05	0.000483	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	4.59e-05	0.00048	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IL2—rheumatoid arthritis	4.58e-05	0.00048	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCR5—rheumatoid arthritis	4.57e-05	0.000478	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CXCL8—rheumatoid arthritis	4.56e-05	0.000478	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	4.53e-05	0.000475	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS2—rheumatoid arthritis	4.48e-05	0.000469	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CSF2—rheumatoid arthritis	4.47e-05	0.000468	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—C3—rheumatoid arthritis	4.46e-05	0.000468	CbGpPWpGaD
Etomidate—Hiccups—Cyclosporine—rheumatoid arthritis	4.44e-05	0.0295	CcSEcCtD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL2—rheumatoid arthritis	4.43e-05	0.000464	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—B3GNT2—rheumatoid arthritis	4.42e-05	0.000463	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ACP5—rheumatoid arthritis	4.42e-05	0.000463	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—rheumatoid arthritis	4.42e-05	0.000463	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CAT—rheumatoid arthritis	4.4e-05	0.000461	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCR6—rheumatoid arthritis	4.4e-05	0.000461	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—SAA1—rheumatoid arthritis	4.33e-05	0.000454	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDE2A—rheumatoid arthritis	4.29e-05	0.000449	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PLB1—rheumatoid arthritis	4.09e-05	0.000429	CbGpPWpGaD
Etomidate—Hiccups—Prednisolone—rheumatoid arthritis	4.04e-05	0.0268	CcSEcCtD
Etomidate—ADRA2B—Hemostasis—IL2RA—rheumatoid arthritis	4.03e-05	0.000422	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL3—rheumatoid arthritis	4.02e-05	0.000421	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL2—rheumatoid arthritis	4.02e-05	0.000421	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—BGN—rheumatoid arthritis	3.98e-05	0.000417	CbGpPWpGaD
Etomidate—Hiccups—Hydrocortisone—rheumatoid arthritis	3.94e-05	0.0262	CcSEcCtD
Etomidate—ADRA2B—Signaling by GPCR—SAA1—rheumatoid arthritis	3.93e-05	0.000412	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—rheumatoid arthritis	3.89e-05	0.000408	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TGFB1—rheumatoid arthritis	3.86e-05	0.000405	CbGpPWpGaD
Etomidate—Hypoxia—Methotrexate—rheumatoid arthritis	3.86e-05	0.0257	CcSEcCtD
Etomidate—ADRA2B—Hemostasis—MMP1—rheumatoid arthritis	3.84e-05	0.000402	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CAT—rheumatoid arthritis	3.79e-05	0.000397	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RBPJ—rheumatoid arthritis	3.78e-05	0.000395	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	3.77e-05	0.000395	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL12—rheumatoid arthritis	3.77e-05	0.000395	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	3.72e-05	0.00039	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	3.72e-05	0.00039	CbGpPWpGaD
Etomidate—Hiccups—Triamcinolone—rheumatoid arthritis	3.71e-05	0.0247	CcSEcCtD
Etomidate—Hiccups—Methylprednisolone—rheumatoid arthritis	3.7e-05	0.0246	CcSEcCtD
Etomidate—CYP11B2—Metabolism—MTHFR—rheumatoid arthritis	3.67e-05	0.000385	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALOX5—rheumatoid arthritis	3.66e-05	0.000383	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	3.63e-05	0.00038	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	3.57e-05	0.000374	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—POMC—rheumatoid arthritis	3.57e-05	0.000374	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	3.51e-05	0.000368	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—FN1—rheumatoid arthritis	3.5e-05	0.000367	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCL2—rheumatoid arthritis	3.49e-05	0.000366	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS2—rheumatoid arthritis	3.46e-05	0.000363	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	3.44e-05	0.00036	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL12—rheumatoid arthritis	3.42e-05	0.000358	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—BDKRB2—rheumatoid arthritis	3.42e-05	0.000358	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADRBK1—rheumatoid arthritis	3.38e-05	0.000354	CbGpPWpGaD
Etomidate—Hiccups—Betamethasone—rheumatoid arthritis	3.37e-05	0.0224	CcSEcCtD
Etomidate—Hiccups—Dexamethasone—rheumatoid arthritis	3.37e-05	0.0224	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—CXCL13—rheumatoid arthritis	3.33e-05	0.000349	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL10—rheumatoid arthritis	3.33e-05	0.000349	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	3.3e-05	0.000345	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.22e-05	0.000337	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—RASGRP1—rheumatoid arthritis	3.19e-05	0.000334	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MTHFR—rheumatoid arthritis	3.16e-05	0.000331	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PRKCQ—rheumatoid arthritis	3.12e-05	0.000327	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL10—rheumatoid arthritis	3.02e-05	0.000317	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	3.01e-05	0.000316	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IRAK1—rheumatoid arthritis	3e-05	0.000315	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TLE3—rheumatoid arthritis	3e-05	0.000315	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ENO1—rheumatoid arthritis	2.98e-05	0.000313	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CX3CR1—rheumatoid arthritis	2.97e-05	0.000311	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—POMC—rheumatoid arthritis	2.94e-05	0.000308	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.93e-05	0.000307	CbGpPWpGaD
Etomidate—Hiccups—Prednisone—rheumatoid arthritis	2.93e-05	0.0195	CcSEcCtD
Etomidate—SLC2A1—Disease—IL6—rheumatoid arthritis	2.91e-05	0.000305	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ALB—rheumatoid arthritis	2.91e-05	0.000305	CbGpPWpGaD
Etomidate—Apnoea—Methotrexate—rheumatoid arthritis	2.89e-05	0.0192	CcSEcCtD
Etomidate—Vomiting—Auranofin—rheumatoid arthritis	2.87e-05	0.0191	CcSEcCtD
Etomidate—ADRA2B—GPCR downstream signaling—CCL5—rheumatoid arthritis	2.87e-05	0.0003	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL2RB—rheumatoid arthritis	2.86e-05	0.0003	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CSF2—rheumatoid arthritis	2.82e-05	0.000296	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS3—rheumatoid arthritis	2.78e-05	0.000292	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—C5—rheumatoid arthritis	2.76e-05	0.000289	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL8—rheumatoid arthritis	2.76e-05	0.000289	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MMP3—rheumatoid arthritis	2.76e-05	0.000289	CbGpPWpGaD
Etomidate—Arrhythmia—Azathioprine—rheumatoid arthritis	2.73e-05	0.0182	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—NFATC1—rheumatoid arthritis	2.72e-05	0.000285	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ALB—rheumatoid arthritis	2.68e-05	0.00028	CbGpPWpGaD
Etomidate—Vomiting—Penicillamine—rheumatoid arthritis	2.65e-05	0.0176	CcSEcCtD
Etomidate—GABRA1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.64e-05	0.000276	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL5—rheumatoid arthritis	2.6e-05	0.000273	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCR6—rheumatoid arthritis	2.6e-05	0.000272	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCR5—rheumatoid arthritis	2.58e-05	0.00027	CbGpPWpGaD
Etomidate—Arrhythmia—Leflunomide—rheumatoid arthritis	2.58e-05	0.0171	CcSEcCtD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.57e-05	0.000269	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CSF2—rheumatoid arthritis	2.56e-05	0.000268	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NOS3—rheumatoid arthritis	2.56e-05	0.000268	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL2RA—rheumatoid arthritis	2.54e-05	0.000266	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—POMC—rheumatoid arthritis	2.53e-05	0.000265	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NCF2—rheumatoid arthritis	2.53e-05	0.000265	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—C3—rheumatoid arthritis	2.52e-05	0.000264	CbGpPWpGaD
Etomidate—Respiratory failure—Methotrexate—rheumatoid arthritis	2.5e-05	0.0166	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—TRAF6—rheumatoid arthritis	2.46e-05	0.000258	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SH2B3—rheumatoid arthritis	2.46e-05	0.000258	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GZMB—rheumatoid arthritis	2.45e-05	0.000256	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL3—rheumatoid arthritis	2.38e-05	0.000249	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL2—rheumatoid arthritis	2.38e-05	0.000249	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IL2—rheumatoid arthritis	2.36e-05	0.000247	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCR5—rheumatoid arthritis	2.34e-05	0.000246	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—rheumatoid arthritis	2.34e-05	0.000245	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SAA1—rheumatoid arthritis	2.32e-05	0.000243	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL2RA—rheumatoid arthritis	2.31e-05	0.000242	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ALB—rheumatoid arthritis	2.31e-05	0.000242	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—C3—rheumatoid arthritis	2.29e-05	0.00024	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NCF1—rheumatoid arthritis	2.28e-05	0.000238	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NOS3—rheumatoid arthritis	2.21e-05	0.000231	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CD28—rheumatoid arthritis	2.19e-05	0.000229	CbGpPWpGaD
Etomidate—Hypertension—Leflunomide—rheumatoid arthritis	2.17e-05	0.0144	CcSEcCtD
Etomidate—CYP19A1—Metabolism—CAT—rheumatoid arthritis	2.15e-05	0.000225	CbGpPWpGaD
Etomidate—Bradycardia—Prednisolone—rheumatoid arthritis	2.06e-05	0.0137	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—UBE2D1—rheumatoid arthritis	2.06e-05	0.000216	CbGpPWpGaD
Etomidate—Hypotension—Azathioprine—rheumatoid arthritis	2.03e-05	0.0135	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—BDKRB2—rheumatoid arthritis	2.02e-05	0.000212	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL12—rheumatoid arthritis	2.02e-05	0.000212	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—rheumatoid arthritis	2.02e-05	0.000211	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—POMC—rheumatoid arthritis	2.02e-05	0.000211	CbGpPWpGaD
Etomidate—Bradycardia—Hydrocortisone—rheumatoid arthritis	2.02e-05	0.0134	CcSEcCtD
Etomidate—ADRA2B—Hemostasis—VEGFA—rheumatoid arthritis	2.01e-05	0.00021	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6ST—rheumatoid arthritis	2e-05	0.00021	CbGpPWpGaD
Etomidate—Tachycardia—Leflunomide—rheumatoid arthritis	2e-05	0.0133	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—ADRBK1—rheumatoid arthritis	2e-05	0.000209	CbGpPWpGaD
Etomidate—Arrhythmia—Cyclosporine—rheumatoid arthritis	1.99e-05	0.0132	CcSEcCtD
Etomidate—Hypotension—Leflunomide—rheumatoid arthritis	1.92e-05	0.0127	CcSEcCtD
Etomidate—Bradycardia—Triamcinolone—rheumatoid arthritis	1.9e-05	0.0126	CcSEcCtD
Etomidate—Bradycardia—Methylprednisolone—rheumatoid arthritis	1.89e-05	0.0126	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.88e-05	0.000197	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SYK—rheumatoid arthritis	1.88e-05	0.000197	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.84e-05	0.000193	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TGFB1—rheumatoid arthritis	1.84e-05	0.000193	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—POMC—rheumatoid arthritis	1.83e-05	0.000192	CbGpPWpGaD
Etomidate—Arrhythmia—Prednisolone—rheumatoid arthritis	1.81e-05	0.012	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—STAT1—rheumatoid arthritis	1.81e-05	0.00019	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MTHFR—rheumatoid arthritis	1.79e-05	0.000188	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL2—rheumatoid arthritis	1.79e-05	0.000188	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6R—rheumatoid arthritis	1.79e-05	0.000187	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL10—rheumatoid arthritis	1.79e-05	0.000187	CbGpPWpGaD
Etomidate—Arrhythmia—Hydrocortisone—rheumatoid arthritis	1.77e-05	0.0118	CcSEcCtD
Etomidate—Pain—Leflunomide—rheumatoid arthritis	1.75e-05	0.0117	CcSEcCtD
Etomidate—Bradycardia—Betamethasone—rheumatoid arthritis	1.72e-05	0.0114	CcSEcCtD
Etomidate—Bradycardia—Dexamethasone—rheumatoid arthritis	1.72e-05	0.0114	CcSEcCtD
Etomidate—Convulsion—Cyclosporine—rheumatoid arthritis	1.68e-05	0.0112	CcSEcCtD
Etomidate—Hypertension—Cyclosporine—rheumatoid arthritis	1.67e-05	0.0111	CcSEcCtD
Etomidate—Arrhythmia—Triamcinolone—rheumatoid arthritis	1.67e-05	0.0111	CcSEcCtD
Etomidate—Arrhythmia—Methylprednisolone—rheumatoid arthritis	1.66e-05	0.011	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—MMP3—rheumatoid arthritis	1.63e-05	0.000171	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—TYK2—rheumatoid arthritis	1.63e-05	0.000171	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTK2—rheumatoid arthritis	1.57e-05	0.000164	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.56e-05	0.000163	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL5—rheumatoid arthritis	1.54e-05	0.000161	CbGpPWpGaD
Etomidate—Convulsion—Prednisolone—rheumatoid arthritis	1.53e-05	0.0102	CcSEcCtD
Etomidate—Hypertension—Prednisolone—rheumatoid arthritis	1.52e-05	0.0101	CcSEcCtD
Etomidate—ADRA2B—Hemostasis—TP53—rheumatoid arthritis	1.52e-05	0.000159	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CSF2—rheumatoid arthritis	1.51e-05	0.000159	CbGpPWpGaD
Etomidate—Arrhythmia—Betamethasone—rheumatoid arthritis	1.51e-05	0.01	CcSEcCtD
Etomidate—Arrhythmia—Dexamethasone—rheumatoid arthritis	1.51e-05	0.01	CcSEcCtD
Etomidate—Bradycardia—Prednisone—rheumatoid arthritis	1.5e-05	0.00997	CcSEcCtD
Etomidate—Convulsion—Hydrocortisone—rheumatoid arthritis	1.49e-05	0.00993	CcSEcCtD
Etomidate—ADRA2B—GPCR downstream signaling—IL2—rheumatoid arthritis	1.49e-05	0.000156	CbGpPWpGaD
Etomidate—Hypertension—Hydrocortisone—rheumatoid arthritis	1.49e-05	0.00989	CcSEcCtD
Etomidate—CYP19A1—Metabolism—POMC—rheumatoid arthritis	1.43e-05	0.00015	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SPP1—rheumatoid arthritis	1.42e-05	0.000149	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.42e-05	0.000148	CbGpPWpGaD
Etomidate—Convulsion—Triamcinolone—rheumatoid arthritis	1.41e-05	0.00935	CcSEcCtD
Etomidate—Tachycardia—Prednisolone—rheumatoid arthritis	1.41e-05	0.00935	CcSEcCtD
Etomidate—Convulsion—Methylprednisolone—rheumatoid arthritis	1.4e-05	0.00933	CcSEcCtD
Etomidate—Hypertension—Triamcinolone—rheumatoid arthritis	1.4e-05	0.00932	CcSEcCtD
Etomidate—Hypertension—Methylprednisolone—rheumatoid arthritis	1.4e-05	0.00929	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—CCR5—rheumatoid arthritis	1.38e-05	0.000145	CbGpPWpGaD
Etomidate—Vomiting—Azathioprine—rheumatoid arthritis	1.38e-05	0.00918	CcSEcCtD
Etomidate—Tachycardia—Hydrocortisone—rheumatoid arthritis	1.37e-05	0.00913	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—IL2RA—rheumatoid arthritis	1.36e-05	0.000143	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL2—rheumatoid arthritis	1.35e-05	0.000142	CbGpPWpGaD
Etomidate—Pain—Cyclosporine—rheumatoid arthritis	1.35e-05	0.009	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—C3—rheumatoid arthritis	1.35e-05	0.000142	CbGpPWpGaD
Etomidate—Arrhythmia—Prednisone—rheumatoid arthritis	1.32e-05	0.00875	CcSEcCtD
Etomidate—Hypotension—Hydrocortisone—rheumatoid arthritis	1.31e-05	0.00874	CcSEcCtD
Etomidate—CYP19A1—Metabolism—ALB—rheumatoid arthritis	1.31e-05	0.000137	CbGpPWpGaD
Etomidate—Vomiting—Leflunomide—rheumatoid arthritis	1.3e-05	0.00867	CcSEcCtD
Etomidate—Tachycardia—Triamcinolone—rheumatoid arthritis	1.29e-05	0.00859	CcSEcCtD
Etomidate—Tachycardia—Methylprednisolone—rheumatoid arthritis	1.29e-05	0.00857	CcSEcCtD
Etomidate—Convulsion—Betamethasone—rheumatoid arthritis	1.28e-05	0.00848	CcSEcCtD
Etomidate—Convulsion—Dexamethasone—rheumatoid arthritis	1.28e-05	0.00848	CcSEcCtD
Etomidate—Hypertension—Betamethasone—rheumatoid arthritis	1.27e-05	0.00845	CcSEcCtD
Etomidate—Hypertension—Dexamethasone—rheumatoid arthritis	1.27e-05	0.00845	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—LEP—rheumatoid arthritis	1.26e-05	0.000132	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NOS3—rheumatoid arthritis	1.25e-05	0.000131	CbGpPWpGaD
Etomidate—Hypotension—Methylprednisolone—rheumatoid arthritis	1.24e-05	0.00821	CcSEcCtD
Etomidate—Pain—Prednisolone—rheumatoid arthritis	1.23e-05	0.00819	CcSEcCtD
Etomidate—Pain—Hydrocortisone—rheumatoid arthritis	1.2e-05	0.008	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—FN1—rheumatoid arthritis	1.19e-05	0.000124	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6ST—rheumatoid arthritis	1.18e-05	0.000124	CbGpPWpGaD
Etomidate—Tachycardia—Betamethasone—rheumatoid arthritis	1.17e-05	0.0078	CcSEcCtD
Etomidate—Tachycardia—Dexamethasone—rheumatoid arthritis	1.17e-05	0.0078	CcSEcCtD
Etomidate—CYP19A1—Metabolism—PTGS2—rheumatoid arthritis	1.14e-05	0.00012	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CD80—rheumatoid arthritis	1.14e-05	0.000119	CbGpPWpGaD
Etomidate—Pain—Triamcinolone—rheumatoid arthritis	1.13e-05	0.00753	CcSEcCtD
Etomidate—Hypotension—Betamethasone—rheumatoid arthritis	1.12e-05	0.00747	CcSEcCtD
Etomidate—Hypotension—Dexamethasone—rheumatoid arthritis	1.12e-05	0.00747	CcSEcCtD
Etomidate—Convulsion—Prednisone—rheumatoid arthritis	1.11e-05	0.00739	CcSEcCtD
Etomidate—Hypertension—Prednisone—rheumatoid arthritis	1.11e-05	0.00736	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—POMC—rheumatoid arthritis	1.08e-05	0.000113	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL2—rheumatoid arthritis	1.06e-05	0.000111	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6R—rheumatoid arthritis	1.06e-05	0.000111	CbGpPWpGaD
Etomidate—Pain—Dexamethasone—rheumatoid arthritis	1.03e-05	0.00683	CcSEcCtD
Etomidate—Pain—Betamethasone—rheumatoid arthritis	1.03e-05	0.00683	CcSEcCtD
Etomidate—Tachycardia—Prednisone—rheumatoid arthritis	1.02e-05	0.00679	CcSEcCtD
Etomidate—Vomiting—Cyclosporine—rheumatoid arthritis	1.01e-05	0.00669	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—TYK2—rheumatoid arthritis	9.62e-06	0.000101	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOS3—rheumatoid arthritis	9.44e-06	9.89e-05	CbGpPWpGaD
Etomidate—Convulsion—Methotrexate—rheumatoid arthritis	9.29e-06	0.00617	CcSEcCtD
Etomidate—Vomiting—Hydrocortisone—rheumatoid arthritis	8.95e-06	0.00595	CcSEcCtD
Etomidate—Vomiting—Triamcinolone—rheumatoid arthritis	8.42e-06	0.0056	CcSEcCtD
Etomidate—Vomiting—Methylprednisolone—rheumatoid arthritis	8.4e-06	0.00559	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—CXCL8—rheumatoid arthritis	8.37e-06	8.77e-05	CbGpPWpGaD
Etomidate—Hypotension—Methotrexate—rheumatoid arthritis	8.17e-06	0.00543	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—IL2—rheumatoid arthritis	8e-06	8.38e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6—rheumatoid arthritis	7.96e-06	8.34e-05	CbGpPWpGaD
Etomidate—Vomiting—Betamethasone—rheumatoid arthritis	7.64e-06	0.00508	CcSEcCtD
Etomidate—Vomiting—Dexamethasone—rheumatoid arthritis	7.64e-06	0.00508	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—MMP9—rheumatoid arthritis	7.57e-06	7.93e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NFKB1—rheumatoid arthritis	7.49e-06	7.85e-05	CbGpPWpGaD
Etomidate—Pain—Methotrexate—rheumatoid arthritis	7.48e-06	0.00497	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—MAPK8—rheumatoid arthritis	7.36e-06	7.71e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—rheumatoid arthritis	6.8e-06	7.12e-05	CbGpPWpGaD
Etomidate—Vomiting—Prednisone—rheumatoid arthritis	6.66e-06	0.00442	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—TGFB1—rheumatoid arthritis	6.24e-06	6.54e-05	CbGpPWpGaD
Etomidate—Vomiting—Methotrexate—rheumatoid arthritis	5.56e-06	0.0037	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—TP53—rheumatoid arthritis	5.14e-06	5.38e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6—rheumatoid arthritis	4.7e-06	4.93e-05	CbGpPWpGaD
